Latest News
Virax Biolabs to commercialize ImmuneSelect Portfolio in UK and Ireland via Europa Biosite partnership
23 October 2024 - Biotechnology company Virax Biolabs Group Limited (NASDAQ: VRAX) on Wednesday announced a new distribution agreement with Europa Biosite for the commercialisation of its ImmuneSelect Research Use portfolio in the United Kingdom and ...
Repare Therapeutics reports positive safety and tolerability data from Phase 1 MYTHIC trial
23 October 2024 - Repare Therapeutics Inc (Nasdaq: RPTX), a clinical-stage precision oncology firm, announced on Wednesday that it has reported updated safety and tolerability results from its Phase 1 MYTHIC clinical trial. The trial evaluates the co...
United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service
23 October 2024 - Public benefit corporation United Therapeutics Corporation (Nasdaq: UTHR) and its subsidiary Lung Bioengineering Inc (LBE) announced on Wednesday that they have achieved a significant milestone, completing the 500th lung transplant ...
Bicycle Therapeutics unveils promising human imaging data at EANM 2024, targeting next-generation radiopharmaceuticals
23 October 2024 - Bicycle Therapeutics (NASDAQ: BCYC) announced on Wednesday that it presented its first human imaging data at the EANM 2024 Congress, confirming the potential of MT1-MMP as a new target for cancer treatment. Data validated the effect...
JCR Pharmaceuticals showcases preclinical gene therapy advances at ESGCT Congress
23 October 2024 - JCR Pharmaceuticals Co, Ltd (TSE 4552) presented promising preclinical data on its adeno-associated virus (AAV) gene therapy research at the European Society of Gene and Cell Therapy's 31st Annual Congress in Rome, held from 22...